Cargando…
Erratum to: Modeling precision treatment of breast cancer
During the type-setting of the final version of the article [1] some of the additional files were swapped. The correct files are republished in this Erratum. The online version of the original article can be found under doi:10.1186/s13059-015-0658-5.
Autores principales: | Daemen, Anneleen, Griffith, Obi L, Heiser, Laura M, Wang, Nicholas J, Enache, Oana M, Sanborn, Zachary, Pepin, Francois, Durinck, Steffen, Korkola, James E, Griffith, Malachi, Hur, Joe S, Huh, Nam, Chung, Jongsuk, Cope, Leslie, Fackler, Mary Jo, Umbricht, Christopher, Sukumar, Saraswati, Seth, Pankaj, Sukhatme, Vikas P, Jakkula, Lakshmi R, Lu, Yiling, Mills, Gordon B, Cho, Raymond J, Collisson, Eric A, van’t Veer, Laura J, Spellman, Paul T, Gray, Joe W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426644/ https://www.ncbi.nlm.nih.gov/pubmed/25962591 http://dx.doi.org/10.1186/s13059-015-0658-5 |
Ejemplares similares
-
Modeling precision treatment of breast cancer
por: Daemen, Anneleen, et al.
Publicado: (2013) -
A robust prognostic signature for hormone-positive node-negative breast cancer
por: Griffith, Obi L, et al.
Publicado: (2013) -
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
por: Daemen, Anneleen, et al.
Publicado: (2012) -
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer
por: Korkola, James E., et al.
Publicado: (2015) -
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer
por: Korkola, James E., et al.
Publicado: (2017)